Syndax

3 followers

Syndax Pharmaceuticals, Inc (Syndax) is a clinical stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The Company’s product candidate, entinostat, which was granted Breakthrough The...

Industries

Employees

51-200

Links


Org chart

Collapse
Nate Ide
Senior Vice President, Market Access And Global Value
Norman Nagl
Vice President, Medical Affairs
Peter Ordentlich
Chief Scientific Officer
Steven Closter
Chief Commercial Officer (cco)
Anjali Ganguli
Chief Business Officer
Luke J. Albrecht
General Counsel and Secretary
Kevin McManus
Chief People Officer

Board & advisors

Pierre Legault
Member Board Of Directors (Chair Audit, Compensation, Strategic Committees, Nominating & Governance)